Epidemiological human studies revealed that decreased activity of the CX3CL1/CX3CR1 pathway due to genetic factors may be associated with a lower risk of atherosclerosis as well as a decreased incidence in the episodes of plaque destabilization [17]. This evidence concerns the gene CX3CL1 and atherosclerosis.